PGIM Active High Yield Bond ETF PHYL 深 滬
等待開盤 02-20 09:30:00 美东时间
35.625
+0.020
+0.06%
華盛通- 最 高35.625
- 今 開35.60
- 成交量 19.92万股
- 最 低 35.59
- 昨 收 35.605
- 總市值 12.27亿
- 52周最高 35.67
- 市盈率 靜 --
- 換手率 0.58%
- 52周最低 30.8907
- 委 比 65.81%
- 總股本 3445.00万
- 歷史最高 35.625
- 量 比 0.95
- 振 幅 0.10%
- 歷史最低 16.2476
- 每 手 1
- 風險率 1.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Aquestive Therapeutics Announces FDA Issuance Of Complete Response Letter For Anaphylm
BRIEF-Aquestive Therapeutics Announces FDA Issuance Of Complete Response Letter For Anaphylm Feb 2 (Reuters) - Aquestive Therapeutics Inc AQST.O : AQUESTIVE THERAPEUTICS ANNOUNCES FDA ISSUANCE OF COMPLETE RESPONSE LETTER FOR ANAPHYLM™ AQUESTIVE THERAPEUTICS INC - DEFICIENCIES LIMITED TO PACKAGING AN
02-02 20:35
BRIEF-Organigram Extends Innovation Investment With Phylos
Dec 31 (Reuters) - Organigram Global Inc OGI.TO: ORGANIGRAM EXTENDS INNOVATION INVESTMENT WITH PHYLOS Source text: ID:nBwbrhPb5a Further company coverage: OGI.TO ((Reuters.Briefs@thomsonreuters.com;))
2025-12-31 19:02
BRIEF-neffy Approved In Japan As The First Needle-Free Epinephrine Nasal Spray For Emergency Anaphylaxis Treatment
Sept 19 (Reuters) - ARS Pharmaceuticals Inc SPRY.O: NEFFY® (EPINEPHRINE NASAL SPRAY) APPROVED IN JAPAN AS THE FIRST AND ONLY NEEDLE-FREE EMERGENCY TREATMENT OF ALLERGIC REACTIONS (ANAPHYLAXIS) ARS PHA...
2025-09-19 20:38
BRIEF-Aquestive Therapeutics Announces That FDA Will Not Require An Advisory Committee Meeting To Discuss New Drug Application For Anaphylm™
Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS ANNOUNCES THAT FDA WILL NOT REQUIRE AN ADVISORY COMMITTEE MEETING TO DISCUSS NEW DRUG APPLICATION FOR ANAPHYLM™ AQUESTIVE THERAPEUTICS INC - P...
2025-09-04 19:01
BRIEF-3D Systems Announces Chief Financial Officer Transition
Aug 20 (Reuters) - 3D Systems Corp DDD.N: 3D SYSTEMS ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION 3D SYSTEMS CORP - PHYLLIS NORDSTROM TO SERVE AS INTERIM CFO OF 3D SYSTEMS 3D SYSTEMS CORP - JEFFREY D....
2025-08-21 04:33
BRIEF-Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW
Aug 14 (Reuters) - Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS ANNOUNCES $75M STRATEGIC FUNDING AGREEMENT WITH RTW TO SUPPORT THE POTENTIAL LAUNCH OF ANAPHYLM™ (EPINEPHRINE) SUBLINGUAL F...
2025-08-14 18:27
QUOTES -Trump, Musk feud escalates over tax bill; Tesla, DJT shares fall
Adds new comment NEW YORK, June 5 (Reuters) - President Donald Trump lashed out on Thursday against Elon Musk, saying he was "disappointed" by the billionaire's public opposition to the sweeping tax-c...
2025-06-06 02:33
PGIM Active High Yield Bond ETF declares $0.2348 dividend
PGIM Active High Yield Bond ETF (NYSEARCA:PHYL) declared $0.2348/share monthly dividend. Payable May 5; for shareholders of record May 1; ex-div May 1. See PHYL Dividend Scorecard, Yield Chart, & Divi...
2025-05-03 02:11
BRIEF-ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions
March 5 (Reuters) - ARS Pharmaceuticals Inc SPRY.O: ARS PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF NEFFY® 1 MG (EPINEPHRINE NASAL SPRAY) FOR TYPE I ALLERGIC REACTIONS, INCLUDING ANAPHYLAXIS, IN PEDIATR...
2025-03-06 06:09
BRIEF-FDA Adds Boxed Warning About Anaphylaxis With Multiple Sclerosis Medicine Glatiramer Acetate (Copaxone, Glatopa)
Jan 22 (Reuters) - FDA: FDA ADDS BOXED WARNING ABOUT ANAPHYLAXIS WITH MULTIPLE SCLEROSIS MEDICINE GLATIRAMER ACETATE (COPAXONE, GLATOPA) (((( Reuters.Briefs@thomsonreuters.com ;));))
2025-01-23 01:58
